A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension

Microvascular dysfunction progressing to pulmonary hypertension can be a primary cause of right ventricular failure or a secondary cause because of an underlying systemic illness. Little is known regarding the etiology and epidemiology of coronary microvascular dysfunction in pulmonary hypertension....

Full description

Bibliographic Details
Main Authors: Cyrus Vahdatpour, Samuel Epstein, Kirk Jones, Madeline Smoot, Alex Parker, John Ryan, Andrew Bryant
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:American Heart Journal Plus
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602223000071
_version_ 1828035771194408960
author Cyrus Vahdatpour
Samuel Epstein
Kirk Jones
Madeline Smoot
Alex Parker
John Ryan
Andrew Bryant
author_facet Cyrus Vahdatpour
Samuel Epstein
Kirk Jones
Madeline Smoot
Alex Parker
John Ryan
Andrew Bryant
author_sort Cyrus Vahdatpour
collection DOAJ
description Microvascular dysfunction progressing to pulmonary hypertension can be a primary cause of right ventricular failure or a secondary cause because of an underlying systemic illness. Little is known regarding the etiology and epidemiology of coronary microvascular dysfunction in pulmonary hypertension. Despite this limitation, its presence has been described in patients with pulmonary hypertension. This review focuses on the pathogenesis of cardiac and pulmonary microvascular dysfunction in pulmonary hypertension. Additionally, this review provides a contemporary assessment on the diagnosis and treatment of microvascular dysfunction in patients in pulmonary hypertension. This topic is important to raise awareness of microvascular dysfunction in the coronary and pulmonary circulation, so that future studies will investigate its impact on the pulmonary hypertension patient cohort.
first_indexed 2024-04-10T15:51:21Z
format Article
id doaj.art-0ea30e00ecb5440a8681b1c9d64cbd35
institution Directory Open Access Journal
issn 2666-6022
language English
last_indexed 2024-04-10T15:51:21Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series American Heart Journal Plus
spelling doaj.art-0ea30e00ecb5440a8681b1c9d64cbd352023-02-11T04:16:32ZengElsevierAmerican Heart Journal Plus2666-60222023-02-0126100255A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertensionCyrus Vahdatpour0Samuel Epstein1Kirk Jones2Madeline Smoot3Alex Parker4John Ryan5Andrew Bryant6Department of Pulmonary Critical Care and Sleep Medicine, University of Florida, Gainesville, FL, USA; Corresponding author at: Department of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, P.O. Box 100225 JHMHC, Gainesville, FL 32610-0225, USA.Department of Medicine, University of Florida, Gainesville, FL, USADepartment of Medicine, University of Florida, Gainesville, FL, USADepartment of Medicine, University of Florida, Gainesville, FL, USADepartment of Cardiology, University of Florida, Gainesville, FL, USADepartment of Cardiovascular Medicine, University of Utah, Salt Lake City, UT, USADepartment of Pulmonary Critical Care and Sleep Medicine, University of Florida, Gainesville, FL, USAMicrovascular dysfunction progressing to pulmonary hypertension can be a primary cause of right ventricular failure or a secondary cause because of an underlying systemic illness. Little is known regarding the etiology and epidemiology of coronary microvascular dysfunction in pulmonary hypertension. Despite this limitation, its presence has been described in patients with pulmonary hypertension. This review focuses on the pathogenesis of cardiac and pulmonary microvascular dysfunction in pulmonary hypertension. Additionally, this review provides a contemporary assessment on the diagnosis and treatment of microvascular dysfunction in patients in pulmonary hypertension. This topic is important to raise awareness of microvascular dysfunction in the coronary and pulmonary circulation, so that future studies will investigate its impact on the pulmonary hypertension patient cohort.http://www.sciencedirect.com/science/article/pii/S2666602223000071Microvascular dysfunctionPulmonary hypertensionRight heart failure
spellingShingle Cyrus Vahdatpour
Samuel Epstein
Kirk Jones
Madeline Smoot
Alex Parker
John Ryan
Andrew Bryant
A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension
American Heart Journal Plus
Microvascular dysfunction
Pulmonary hypertension
Right heart failure
title A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension
title_full A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension
title_fullStr A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension
title_full_unstemmed A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension
title_short A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension
title_sort review of cardio pulmonary microvascular dysfunction in pulmonary hypertension
topic Microvascular dysfunction
Pulmonary hypertension
Right heart failure
url http://www.sciencedirect.com/science/article/pii/S2666602223000071
work_keys_str_mv AT cyrusvahdatpour areviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT samuelepstein areviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT kirkjones areviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT madelinesmoot areviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT alexparker areviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT johnryan areviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT andrewbryant areviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT cyrusvahdatpour reviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT samuelepstein reviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT kirkjones reviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT madelinesmoot reviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT alexparker reviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT johnryan reviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension
AT andrewbryant reviewofcardiopulmonarymicrovasculardysfunctioninpulmonaryhypertension